Glycemic Index Ltd is a not-for-profit company formed by the University of Sydney, the Juvenile Diabetes Research Foundation, and Diabetes Australia, which is committed to promoting and contributing to the prevention and management of overweight/obesity, diabetes and other chronic lifestyle-related conditions, through healthier, low-GI diets. At the heart of GIL is the GI Symbol Program, a food labelling program designed to help consumers choose healthy foods that will also lower the average GI of their diets, by providing GI information on food products that meet the strict nutrient content criteria (consistent with the dietary guidelines) within their appropriate food category
Mossman Central Mill Company Limited was founded in 1894 and first commenced raw sugar manufacturing in 1897. Situated in picturesque Far North Queensland, Mossman Mill crushes on average 500,000 to 600,000 tonnes of sugar cane each season. In early 2000, Mossman Mill made a commitment to pursue value-adding opportunities in the production of raw sugar and its by-products from sugar cane. In 2004 Mossman Mill joined forces with Dr David Kannar and Dr Barry Kitchen from Horizon Science to commence working on the development and production of the world’s first natural low GI cane sugar. In 2007, Mossman Mill commissioned a state-of-the-art bagging plant and became the first HACCP accredited primary sugar mill in Queensland. This has enabled the Mill to supply food grade raw sugar to domestic and international markets. During the 2008 crushing season, the world’s first commercial production of a 100% natural low GI cane sugar commenced at Mossman Mill in Far North Queensland, Australia.
La Trobe University is one of Australia’s leading research universities. A member of the Innovative Research Universities, Australia network, it has a world-wide reputation for academic excellence and innovation and attracts more than $340 million per year in research funding. The School of Psychological Science is a key player in that research effort. Its particular strengths are in behavioural neuroscience, clinical psychology, cognitive and developmental psychology, and social and intercultural psychology.
Dr Weisinger, an Associate Professor in the School of Psychological Science, has a PhD from the University of Washington, Seattle. He has over 30 years of expertise in the investigation of mechanisms involved in the control of body fluid and energy homeostasis. His research laboratory on La Trobe University’s main Melbourne campus at Bundoora deals primarily with the influence of nutrition on the mechanisms involved in the control of body weight. During the last four years, he has been working with Horizon Science on the influence of sugarcane derived polyphenols on body composition and insulin sensitivity.
BSES Limited has been serving the Australian sugar industry since 1900 and is the principal provider of research, development and extension services to the Australian sugarcane industry. BSES conducts a diverse R&D portfolio across areas such as conventional plant breeding, biotechnology research and development, improved cropping systems, cane and sugar quality, application of NIR technologies, non-sugar byproducts, extension programs and enhancing variety adoption practices. These activities are performed through its network of research stations, centres and laboratories that are located in 17 cane growing areas throughout Queensland and northern New South Wales. BSES has strong collaborative linkages with organisations such as CSIRO, QDPI&F, Sugar Research and Development Corporation, and the CRC for Sugar Industry Innovation through Biotechnology (CRCSIIB), while also maintaining strong alliances with a number of international companies, academic institutions and research organisations.
CSIRO is Australia’s national science agency and one of the largest and most diverse research agencies in the world. CSIRO works with Horizon Science through CSIRO’s joint venture with the Victorian Government, Food Science Australia (FSA). As Australia’s leading food and nutrition research organisation FSA works with government and industry partners to improve the competitiveness of the Australian food sector and the health of the Australian community. CSIRO’s research and strategic partnerships develop market-relevant and novel products and innovative processes to improve community health and vitality, enhance product quality, ensure food safety and security, increase processing efficiency and sustainability, support industry innovation and increase market access.
With a heritage spanning over 150 years, CSR is Australia’s most trusted sugar brand. The experts in sugar, CSR’s sugar range spans across traditional white table sugar, baking and cooking sugars, to more unique sugars such as Demerara and Jam Setting Sugar. In 2009, CSR, in partnership with Horizon Science, have used innovation and world first technology to develop a low GI sugar – CSR LoGiCane. As part of a new array of sugars that makes up CSR’s Better for You range, LoGiCane has a lower GI than regular sugar and can help keep energy levels balanced and help with satiety between meals. CSR remains committed to being at the forefront of innovation and development within the sugar category.
The New Zealand Sugar Company has a strong and proud heritage spanning 125 years. Seen as the expert in sugar, their iconic Chelsea brand holds the dominant market position in New Zealand and is the foremost for trusted quality, dependable service and a range well aligned with consumer demands. Chelsea Sugar offers an extensive range from everyday sugars to value added premium sugars, syrups and sugar blends, across multi channel and wider export markets. In November 2009, Chelsea Sugar in partnership with Horizon Science delivered the most exciting news and a world first innovation to the New Zealand sugar category – Chelsea LoGiCane™ Low GI Cane Sugar. The changing consumer dynamic and demands for “Better For You” food platforms has lead to the timely launch of LoGiCane™ Low GI Cane Sugar as Chelsea’s most significant and innovative product launch. Innovation and development are key pillars in the New Zealand Sugar Company’s strategic platform.
Inventages is one of the world’s biggest life science and consumer goods venture capital investor with US$ 1.5 billion committed capital. It invests globally in healthcare, nutrition and wellness and operates out of four offices: Geneva (Switzerland), Nassau (Bahamas), Auckland (New Zealand) and London (England).
BioPacificVentures is Australasia’s largest health & wellness venture capital fund, specialising in the convergence of food and health with a focus on prevention, nutrition, food technology and agbiotech. The fund targets pursues investment opportunities in the range from NZ$2 million to NZ$15 million. BioPacificVentures is supported by strategic and financial investors with global reach and industry specific expertise. While investments are made across the whole life science spectrum, BioPacificVentures has a particular focus on opportunities in the emerging “wellness through prevention” market, reflecting the increasing trend in healthcare towards the prevention of chronic diseases. Opportunities of particular interest include functional and medical foods, nutraceuticals, cosmeceuticals, skin care, dietary supplements, infant and sports nutrition, immune stimulation and anti-aging therapies. BioPacificVentures has a strong internationally experienced management team of which Dr Andrew Kelly sits on the Board of Horizon Science.
The Faculty of Medicine, Nursing and Health Sciences at Monash University is the largest research faculty within the largest university in Australia. Over 10,000 students are enrolled in the Faculty which has over 6000 staff members. The Faculty consists of ten schools and also includes the Monash Institute of Medical Research (MIMR) and the Australian Regenerative Medicine Institute (ARMI) which in turn houses the European Molecular Biology Laboratory – Australia (EMBL-A). In 2010 the Faculty is offering over 86 postgraduate programs, and is consistently ranked in the top tier of Australian universities for teaching and learning quality in healthcare disciplines. The prestigious Times Higher Education rankings place Monash at #25 in the world – a significant achievement for a University that recently celebrated only its 50th anniversary. The research expertise of the Faculty is reflected through its competitiveness for grant funding, particularly from the National Health and Medical Research Council(NHMRC) and Australian Research Council (ARC). Monash University operates across eight campuses in three continents: Australia (Clayton, Caulfield, Berwick, Peninsula, Parkville and Gippsland), Malaysia (Sunway campus in Kuala Lumpur), and South Africa (Johannesburg), and through a centre in Prato, Italy. The Faculty also has a significant presence at major teaching hospitals in Melbourne and regional Victoria, and in Malaysia. Monash University belongs both the M8 Alliance of leading medical universities and teaching hospitals worldwide, and the ‘Group of Eight’ of the largest and most prestigious research universities in Australia.